Jeremy Anderson, DPM
Podiatrist · Las Vegas, NVNPI 1144714296
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,514 of the $72,332 with a category attached, or 69.8%. Heron Therapeutics, Inc. accounts for 99.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $46,244 and has fallen 99.9% since, to $33 in 2025. Among podiatrist clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $574.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heron Therapeutics, Inc.$72K
- Bioventus LLC$61
- Integra Lifesciences Corporation$46
- Treace Medical Concepts, Inc.$21
- Nevro Corp.$20
- Smith+Nephew$16
What the payments were for
- Consulting fees$4,5066%
- Speaking & faculty fees$50,51470%
- Travel & lodging$15,05121%
- Food & beverage$2,2613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heron Therapeutics, Inc. | 118 | $72,168 |
| Bioventus LLC | 3 | $61 |
| Integra Lifesciences Corporation | 2 | $46 |
| Treace Medical Concepts, Inc. | 1 | $21 |
| Nevro Corp. | 1 | $20 |
| Smith+Nephew | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$72,332 in reported general payments places this provider in the 95th percentile of 44 podiatrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 21 | $447 |
| Cephalexin | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Las Vegas
- Anthony RicciardiLas Vegas$498K
- He XuLas Vegas$54K
- Peter BregmanLas Vegas$18K
- Anmy VuLas Vegas$15K
- Ai Quoc HellerLas Vegas$8K
- John CadeLas Vegas$6K
- Ada VeraLas Vegas$5K
- Michael ChildsLas Vegas$4K
- Justin ColarcoLas Vegas$2K
- Sofia HossainLas Vegas$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.